Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by Boomskidon Aug 24, 2023 1:44am
88 Views
Post# 35603166

RE:RE:RE:TT's Sappy Cap Plot

RE:RE:RE:TT's Sappy Cap PlotSabby Capital, Sabby Management, and founder Hal David Mintz, have been charged by the SEC with fraud for naked short selling and order making.

I have no idea why TheTruth1234 says that something like this went on with Ladenberg Thalmann. That's kind of a dangerous accuation for TT to make.

My opinion, that I've expressed several times, is that LT appears to have been legally very tight with the Midatech/Bioasis "merger" execution.

The problem for me is that Bioasis, with or without participation or advice from LT downplayed Bioasis's main asset to such a point that it raises some serious questions about whether Dr. Deborah Rathjen was working entirely for the shareholders on the deal. As Evens & Evans pointed out, Rathjen and Saltarelli may have had conflicts of interests.

The unfolding events and actions at Bioasis over the term of the the company's relationship with Ladenberg Thalmann allow an argument to be made and difficult to argue against that Bioasis was badly damaged by those events, either through incompetence, negligence or malice on the part of Bioasis management and BoD.

And what value was there in Bioasis other than the value of xB3? None!

Why would heavu hitters like Armistice and Ladenberg Thalmann work for almost 2 years to get the deal done, with no or little pay, to get the deal done?

xB3

jd
<< Previous
Bullboard Posts
Next >>